Gene Expression Outcomes in Interventions for Substance Using HIV+ Minority Men
Not Applicable
Completed
- Conditions
- InflammationHuman Immunodeficiency Virus Infection
- Interventions
- Behavioral: Writing tasksBehavioral: AWARENESS for Sexual Minorities
- Registration Number
- NCT03143205
- Lead Sponsor
- University of California, San Francisco
- Brief Summary
This is a pilot study of a new 9-session individually delivered cognitive behavioral intervention targeting sexual minority stress. In this study, 40 HIV+ men sexual minority men will be recruited for the study then will be randomly assigned to either the new 9 session intervention or a writing task condition.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Male
- Target Recruitment
- 40
Inclusion Criteria
- Provide evidence or documentation of HIV positive status (e.g. a letter of diagnosis or medication bottles with matched photo ID)
- Be English speaking
- Be able to consent
- Sexual activity with a man in the 3 years prior to initial contact or identification as gay or bisexual
- Not currently be enrolled in formal substance abuse treatment
- Report at least one occasion of drinking 5 or more drinks or of using an illicit substance in the previous 3 months, but not meet criteria for a severe substance use disorder.
Read More
Exclusion Criteria
- Presence of a severe substance use disorder
- Presence of current symptoms consistent with schizophrenia or bipolar disorder, which would indicate that an intervention targeting these symptoms would be more appropriate.
Read More
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Writing tasks Writing tasks Group receives writing-based sessions AWARENESS for sexual minorities AWARENESS for Sexual Minorities Group receives new CBT-based intervention
- Primary Outcome Measures
Name Time Method Change in Gene expression Baseline, ~9 weeks (at conclusion of intervention), 4 month follow-up Gene expression related to inflammation measured in blood
- Secondary Outcome Measures
Name Time Method Change in Substance Use Baseline, ~9 weeks (at conclusion of intervention), 4 month follow-up Substance Use measured through Alcohol Smoking and Substance Involvement Screening Test (ASSIST)
Trial Locations
- Locations (1)
University of California, San Francisco
🇺🇸San Francisco, California, United States